Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Multiple myeloma

Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015–2017

Amal AlZahmi, Irena Cenzer, Ulrich Mansmann, Helmut Ostermann, Sebastian Theurich, Tobias Schleinkofer, Karin Berger

published 28 Jul 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort

Nadjoua Maouche, Bhuvan Kishore, Zara Bhatti, Supratik Basu, Farheen Karim, Sharadha Sundararaman, Freya Collings, Bing Tseu, Heather Leary, Noel Ryman, Udaya Reddy, Grant D. Vallance, Jaimal Kothari, Karthik Ramasamy

published 07 Jul 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Vγ9Vδ2 T cells expressing a BCMA—Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth

Xi Zhang, Yu Yang Ng, Zhicheng Du, Zhendong Li, Can Chen, Lin Xiao, Wee Joo Chng, Shu Wang

published 16 Jun 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Response rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma

Patrick Daniele, Carla Mamolo, Joseph C. Cappelleri, Timothy Bell, Alexander Neuhof, Gabriel Tremblay, Mihaela Musat, Anna Forsythe

published 12 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients

Jillian C. Thompson, Yi Ren, Kristi Romero, Meagan Lew, Amy T. Bush, Julia A. Messina, Sin-Ho Jung, Sharareh Siamakpour-Reihani, Julie Miller, Robert R. Jenq, Jonathan U. Peled, Marcel R. M. van den Brink, Nelson J. Chao, Mark G. Shrime, Anthony D. Sung

published 04 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling

Sook-Kyoung Heo, Eui-Kyu Noh, Hye Jin Seo, Yoo Jin Lee, SuJin Koh, Young Joo Min, Yunsuk Choi, Jae-Cheol Jo

published 03 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)

Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal, Naveen Kumar Khare, Vishal Jadhav, Murarilal Gurjar, Sachin Punatar, Anant Gokarn, Avinash Bonda, Lingaraj Nayak, Sadhana Kannan, Vikram Gota, Navin Khattry, Indraneel Mittra

published 04 Feb 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM

Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, Youngil Koh, Sock-Won Yoon, Dong-Yeop Shin, Junshik Hong, Inho Kim

published 27 Jan 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients

Faouzi Djebbari, Alexandros Rampotas, Fotios Panitsas, Wen Yuen Lim, Charlotte Lees, Ismini Tsagkaraki, Ana Rita Gomes, Steve Prideaux, Lucia Chen, Catherine Prodger, Akhil Khera, Nicola Gray, Lauren Ellis, Gina Sangha, Toby A. Eyre, Sally Moore, Jaimal Kothari, Karthik Ramasamy

published 11 Jan 2022

Loading metrics information...

Metrics unavailable. Please check back later.

The real-world outcomes of multiple myeloma patients treated with daratumumab

Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Emil Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Katrine Fladeland Iversen, Elena Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted

published 13 Oct 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19

Noorwati Sutandyo, Sri Agustini Kurniawati, Achmad Mulawarman Jayusman, Anisa Hana Syafiyah, Raymond Pranata, Arif Riswahyudi Hanafi

published 23 Sep 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Machine learning predicts treatment sensitivity in multiple myeloma based on molecular and clinical information coupled with drug response

Lucas Venezian Povoa, Carlos Henrique Costa Ribeiro, Israel Tojal da Silva

published 28 Jul 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study

Akiko Yamada, Yoichi Araki, Yuko Tanaka, Shunsuke Otsuki, Arisa Yamada, Mitsuru Moriyama, Seiichiro Katagiri, Tamiko Suguro, Michiyo Asano, Seiichiro Yoshizawa, Daigo Akahane, Nahoko Furuya, Hiroaki Fujimoto, Seiichi Okabe, Moritaka Gotoh, Kunihito Suzuki, Kazuhiro Saito, Akihiko Gotoh

published 09 Jul 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Tweets by @plosone

Advertisement

Create a weekly email alert for: Multiple myeloma

You can change these options by clicking profile then "Alerts and Notifications"